Achillea Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 18 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -11.85%
- Profit Growth 1051.19%
- Ebitda 476.23%
- Net Worth 21.14%
- Total Assets -5.81%
About Achillea Life Sciences
Achillea Life Sciences Private Limited (ALSPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 January 2016 (Nine years 18 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Praveen Singh, Navinkumar Singh, Rajesh Tiwari, and One other member serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U74120MH2016PTC272015
- Company No.
272015
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jan 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Achillea Life Sciences?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Tiwari  | Director | 17-Mar-2018 | Current |
| Praveen Singh | Director | 13-Jan-2016 | Current |
| Navinkumar Singh | Director | 13-Jan-2016 | Current |
| Niraj Singh | Director | 17-Mar-2018 | Current |
Financial Performance of Achillea Life Sciences.
Achillea Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 11.85% decrease. The company also saw a substantial improvement in profitability, with a 1051.19% increase in profit. The company's net worth Soared by an impressive increase of 21.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Achillea Life Sciences?
Unlock access to Achillea Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Achillea Life Sciences?
Unlock and access historical data on people associated with Achillea Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Achillea Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Achillea Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
